Published in J Alzheimers Dis on January 01, 2017
Migraine--current understanding and treatment. N Engl J Med (2002) 9.80
Leisure activities and the risk of dementia in the elderly. N Engl J Med (2003) 8.77
Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ (2009) 4.98
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache (2010) 4.37
Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry (2007) 3.92
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med (2006) 3.90
Abnormality of gait as a predictor of non-Alzheimer's dementia. N Engl J Med (2002) 3.88
Obesity and migraine: a population study. Neurology (2005) 3.67
Cognitive processes related to gait velocity: results from the Einstein Aging Study. Neuropsychology (2006) 3.34
Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc (2008) 3.21
Validity of divided attention tasks in predicting falls in older individuals: a preliminary study. J Am Geriatr Soc (2002) 3.18
Lipoprotein genotype and conserved pathway for exceptional longevity in humans. PLoS Biol (2006) 3.12
Quantitative gait markers and incident fall risk in older adults. J Gerontol A Biol Sci Med Sci (2009) 3.01
Screening for dementia by telephone using the memory impairment screen. J Am Geriatr Soc (2003) 2.92
Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology (2008) 2.87
Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache (2007) 2.75
Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc (2003) (2004) 2.45
Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc (2006) 2.35
Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc (2003) (2004) 2.32
The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain (2005) 2.25
The relationship between specific cognitive functions and falls in aging. Neuropsychology (2007) 2.17
Post-dural puncture headache: part I diagnosis, epidemiology, etiology, and pathophysiology. Headache (2010) 2.17
Motoric cognitive risk syndrome and the risk of dementia. J Gerontol A Biol Sci Med Sci (2012) 2.12
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache (2007) 2.09
The effect of a family therapy and technology-based intervention on caregiver depression. Gerontologist (2003) 2.09
Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord (2012) 2.02
Walking while talking: effect of task prioritization in the elderly. Arch Phys Med Rehabil (2007) 2.01
Gait dysfunction in mild cognitive impairment syndromes. J Am Geriatr Soc (2008) 2.00
Within-person across-neuropsychological test variability and incident dementia. JAMA (2008) 1.98
Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache (2008) 1.95
Mechanisms of association between obesity and chronic pain in the elderly. Pain (2011) 1.94
Telephone screening for amnestic mild cognitive impairment. Neurology (2003) 1.93
Can patients with epilepsy predict their seizures? Neurology (2007) 1.90
Peripheral nerve blocks and trigger point injections in headache management - a systematic review and suggestions for future research. Headache (2010) 1.88
Outcomes of mild cognitive impairment by definition: a population study. Arch Neurol (2011) 1.84
Excessive acute migraine medication use and migraine progression. Neurology (2008) 1.83
Picture-based memory impairment screen for dementia. J Am Geriatr Soc (2012) 1.82
The epidemiology, burden, and comorbidities of migraine. Neurol Clin (2009) 1.81
Modeling memory decline in older adults: the importance of preclinical dementia, attrition, and chronological age. Psychol Aging (2003) 1.79
Psychiatric comorbidity of migraine. Headache (2006) 1.77
Reliability and validity of a telephone-based mobility assessment questionnaire. Age Ageing (2004) 1.77
Screening for predementia AD: time-dependent operating characteristics of episodic memory tests. Neurology (2013) 1.75
Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology (2004) 1.75
Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disord (2004) 1.73
Migraine and autonomic nervous system function: a population-based, case-control study. Neurology (2002) 1.71
Diffusion-tensor imaging implicates prefrontal axonal injury in executive function impairment following very mild traumatic brain injury. Radiology (2009) 1.65
Age-dependent prevalence and clinical features of migraine. Neurology (2006) 1.61
Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology (2006) 1.60
Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache (2009) 1.59
Screening for Alzheimer's disease: the memory impairment screen versus the conventional three-word memory test. J Am Geriatr Soc (2002) 1.59
Excessive opioid use and the development of chronic migraine. Pain (2009) 1.55
Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology (2007) 1.55
Assessment of potential drug-drug interactions with a prescription claims database. Am J Health Syst Pharm (2005) 1.54
Body mass index and episodic headaches: a population-based study. Arch Intern Med (2007) 1.54
Psychiatric comorbidities of episodic and chronic migraine. J Neurol (2012) 1.53
Chronic pain and obesity in elderly people: results from the Einstein aging study. J Am Geriatr Soc (2008) 1.53
Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache (2003) 1.53
Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society. Headache (2008) 1.51
Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache (2012) 1.51
The prevalence of migraine in neurologists. Neurology (2003) 1.49
Guidelines for trials of behavioral treatments for recurrent headache, first edition: American Headache Society Behavioral Clinical Trials Workgroup. Headache (2005) 1.47
White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol (2013) 1.47
Chronic migraine: epidemiology and disease burden. Curr Pain Headache Rep (2011) 1.46
Regional prefrontal gray and white matter abnormalities in bipolar disorder. Biol Psychiatry (2002) 1.45
Regional white matter and neuropsychological functioning across the adult lifespan. Biol Psychiatry (2006) 1.44
Adiponectin levels and genotype: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci (2008) 1.44
Head or neck injury increases the risk of chronic daily headache: a population-based study. Neurology (2007) 1.43
Robust norms for selected neuropsychological tests in older adults. Arch Clin Neuropsychol (2008) 1.41
Headache associated with moyamoya disease: a case story and literature review. J Headache Pain (2009) 1.41
Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry (2002) 1.40
Coexisting trigeminal autonomic cephalalgias and hemicrania continua. Headache (2010) 1.40
Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache (2004) 1.39
Assessing the quality of health-related quality of life measures. Cephalalgia (2012) 1.39
The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis. Value Health (2008) 1.39
Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter? Dialogues Clin Neurosci (2009) 1.38
Changing physician knowledge, attitudes, and beliefs about migraine: evaluation of a new educational intervention. Headache (2006) 1.38
Is migraine a progressive brain disease? JAMA (2004) 1.36
The epidemiology of primary headache disorders. Semin Neurol (2010) 1.36
Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia. JAMA (2010) 1.35
Modifiable risk factors for migraine progression. Headache (2006) 1.34
Validity of spiral analysis in early Parkinson's disease. Mov Disord (2008) 1.32
Risk factors for headache chronification. Headache (2008) 1.27
Reliability and validity of an algorithm for the diagnosis of normal cognition, mild cognitive impairment, and dementia: implications for multicenter research studies. Am J Geriatr Psychiatry (2010) 1.27
Epidemiology and biology of menstrual migraine. Headache (2008) 1.26